We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





AI Takes Guesswork Out Of Lateral Flow Testing

By LabMedica International staff writers
Posted on 19 Oct 2022
Print article
Image: Researchers show that machine learning-based apps could be beneficial for diagnostic testing at home (Photo courtesy of Pexels)
Image: Researchers show that machine learning-based apps could be beneficial for diagnostic testing at home (Photo courtesy of Pexels)

An artificial intelligence (AI) app to read COVID-19 lateral flow tests helped to reduce false results in a new trial.

A team of researchers from the University of Birmingham (Birmingham, UK), Durham University (Durham, UK) and Oxford University (Oxford, UK) tested whether a machine learning algorithm could improve the accuracy of results from antigen lateral flow devices for COVID-19. The LFD AI Consortium team worked at UK Health Security Agency assisted test centres and with health care workers conducting self-testing to trial the AI app. More than 100,000 images were submitted as part of the study, and the team found that the algorithm was able to increase the sensitivity of results, determining between a true positive and false negative, from 92% to 97.6% accuracy.

“The widespread use of antigen lateral flow devices was a significant moment not just during the pandemic, but has also introduced diagnostic testing to many more people in society. One of the drawbacks with LFD testing for COVID, pregnancy and any other future use is the ‘faint line’ question – where we can’t quite tell if it’s a positive or not,” said Professor Andrew Beggs, Professor of Cancer Genetics & Surgery at the University of Birmingham and lead author of the study. “The study looked at the feasibility of using machine learning to take the guesswork out of the faint line tests, and we’re pleased to see that the app saw an increase in sensitivity of the tests, reducing the numbers of false negatives. The promise of this type of technology could be used in lots of applications, both to reduce uncertainty about test results and provide a crucial support for visually impaired people.”

“The increase in sensitivity and overall accuracy is significant and it shows the potential of this app by reducing the number of false negatives and future infections. Crucially, the method can also be easily adapted to the evaluation of other digital readers for lateral flow type devices,” added Professor Camila Caiado, Professor of Statistics at Durham University and chief statistician on the project.

Related Links:
University of Birmingham
Durham University
Oxford University

Gold Member
COVID-19 Rapid Test
AQ+ COVID-19 Ag Rapid Test
Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
New
Entamoeba Test
RIDASCREEN Entamoeba Test
New
Hematology Analyzer
XS-500i

Print article

Channels

Molecular Diagnostics

view channel
Image: The groundbreaking genomics method has the potential to uncover insights previously missed (Photo courtesy of Breakthrough Genomics)

Groundbreaking Blood Test Detects Earliest Signs of Pancreatic Cancer Before Symptoms Appear

Pancreatic cancer often remains undetected until it has progressed beyond the pancreas, typically because it presents no noticeable symptoms in its early stages. Consequently, pancreatic cancer has one... Read more

Hematology

view channel
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)

New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape

The release of oxygen by red blood cells is a critical process for oxygenating the body's tissues, including organs and muscles, particularly in individuals receiving large blood transfusions.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The iFAST reader scans 5000 individual bacteria with each sample analyzed in less than a minute (Photo courtesy of iFAST)

High-Throughput AST System Uses Microchip Technology to Rapidly Analyze Bacterial Samples

Bacteria are becoming increasingly resistant to antibiotics, with resistance levels ranging from 20% to 98%, and these levels are unpredictable. Currently, antimicrobial susceptibility testing (AST) takes... Read more

Pathology

view channel
Image: These images show the high resolution achieved with the new microscopy technique (Photo courtesy of Cao, R. et al. Science Advance, 2024. Caltech)

New Microscopy Technique Enables Rapid Tumor Analysis by Surgeons in OR

The current standard method for quickly sampling and imaging tissue during surgery involves taking a biopsy, freezing the sample, staining it to enhance visibility, and slicing it into thin sections that... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.